Cloning And Mutagenesis Market Size, Growth, Trends | Report 2022-2030
Cloning is the process in which an exact or identical genetic replica, biological entity, or identical organism, cell or tissue is produced by natural or artificial means. It is an asexual type of reproduction. Examples of natural clone technology are binary fission in bacteria and animal parthenogenesis. The artificial clone technology is done using a biotechnology procedure. Example - Embryo splitting in animals and nuclear transfer. Mutagenesis is the process in which the DNA of the organism is changed or altered which results in the mutation of the genes. It causes an innate or permanent change in the genetic material or DNA. It can be self-imposed when the environmental conditions restrict the growth of the organisms (unicellular organisms). Example- Growth of bacteria in the presence of antibiotics.
Cloning and mutagenesis techniques are used to study the structure and function of proteins and to confirm the mutation effects in vitro and in vivo. The market is expected to grow due to an increase in the use of cloning techniques in various genetic fields like reproductive cloning.
There are three types of cloning, gene (gene or DNA segment creation), reproductive (create whole animal copy), and therapeutic cloning (creates stem cells-embryonic based). It has a wide range of applications like gene therapy, agricultural application in producing pest-resistant plants, the creation of transgenic animals, and so on. Example- Bacterial cloning smoothens the nitrogen fixation in plants. Mutagenesis has different types such as directed mutagenesis, random mutagenesis, insertional mutagenesis, and PCR mutagenesis. Mutagenesis has a wide range of applications in plant breeding, genetic study, protein engineering, etc.
The prevalence of genetic disorders, and chronic diseases are increasing nowadays globally. Due to this, there is more demand for personalized medicine in the market which eventually accelerates the market. There is raising awareness amongst the biotechnology and pharmaceutical companies for launching products to overcome the stress of these disorders along with HIV and cancer which paves the way for market growth. Government funding in R&D for improvement in healthcare also drives the market. In 2018, a real-time PCR detection kit iQ-Check Vibrio was launched by Bio-Rad Laboratories. It has faster PCR results and is an alternative to Vibrio detection. The use of therapeutic proteins developed vaccines, and advancements in synthetic biology also have a positive impact on the market growth.
The market is segmented into the type, product, technique, application, end-user, and region. The type segment is divided into standard gene, complex gene. The product segment is divided into cloning kits, mutagenesis kits. The technique segment is divided into topo PCR cloning, blunt end cloning, seamless cloning, and site-directed mutagenesis. The application segment is divided into gene synthesis, gene expression, gene therapy, and vaccine research. The end-user segment is divided into pharmaceutical and biotechnology companies and clinical laboratories. Based on region, the market is further segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
As per the regional analysis research, North America holds the market due to the advanced healthcare and research facilities available. Moreover, the government and biotechnology companies are focused on the advancements in cancer and stem cell research in North America which drives market growth. Asia-Pacific region also holds a significant market due to the improved infrastructure of the healthcare facilities, better healthcare reimbursement policies, and better economic growth with positively boosts the market.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cloning And Mutagenesis Market
5.1. COVID-19 Landscape: Cloning And Mutagenesis Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Cloning And Mutagenesis Market, By Type
8.1. Cloning And Mutagenesis Market, by Type, 2022-2030
8.1.1. Standard Gene
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Complex Gene
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Cloning And Mutagenesis Market, By Product
9.1. Cloning And Mutagenesis Market, by Product, 2022-2030
9.1.1. Cloning Kits
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Mutagenesis Kits
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Cloning And Mutagenesis Market, By Technique
10.1. Cloning And Mutagenesis Market, by Technique, 2022-2030
10.1.1. Topo PCR Cloning
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Blunt End Cloning
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Seamless Cloning
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Site-Directed Mutagenesis
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Cloning And Mutagenesis Market, By Application
11.1. Cloning And Mutagenesis Market, by Application, 2022-2030
11.1.1. Gene Synthesis
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Gene Expression
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Gene Therapy
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Vaccine Research
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Cloning And Mutagenesis Market, By End user
12.1. Cloning And Mutagenesis Market, by End user, 2022-2030
12.1.1. Pharmaceutical and Biotechnology Companies
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Clinical Laboratories
12.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Cloning And Mutagenesis Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.3. Market Revenue and Forecast, by Technique (2017-2030)
13.1.4. Market Revenue and Forecast, by Application (2017-2030)
13.1.5. Market Revenue and Forecast, by End user (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Technique (2017-2030)
13.1.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.1.7. Market Revenue and Forecast, by End user (2017-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.8.3. Market Revenue and Forecast, by Technique (2017-2030)
13.1.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.1.8.5. Market Revenue and Forecast, by End user (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.3. Market Revenue and Forecast, by Technique (2017-2030)
13.2.4. Market Revenue and Forecast, by Application (2017-2030)
13.2.5. Market Revenue and Forecast, by End user (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Technique (2017-2030)
13.2.7. Market Revenue and Forecast, by Application (2017-2030)
13.2.8. Market Revenue and Forecast, by End user (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Technique (2017-2030)
13.2.10. Market Revenue and Forecast, by Application (2017-2030)
13.2.11. Market Revenue and Forecast, by End user (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.12.3. Market Revenue and Forecast, by Technique (2017-2030)
13.2.12.4. Market Revenue and Forecast, by Application (2017-2030)
13.2.13. Market Revenue and Forecast, by End user (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.14.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Technique (2017-2030)
13.2.14.4. Market Revenue and Forecast, by Application (2017-2030)
13.2.15. Market Revenue and Forecast, by End user (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.3. Market Revenue and Forecast, by Technique (2017-2030)
13.3.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.5. Market Revenue and Forecast, by End user (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Technique (2017-2030)
13.3.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.7. Market Revenue and Forecast, by End user (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Technique (2017-2030)
13.3.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.9. Market Revenue and Forecast, by End user (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Technique (2017-2030)
13.3.10.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.10.5. Market Revenue and Forecast, by End user (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.11.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Technique (2017-2030)
13.3.11.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.11.5. Market Revenue and Forecast, by End user (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.3. Market Revenue and Forecast, by Technique (2017-2030)
13.4.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.5. Market Revenue and Forecast, by End user (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Technique (2017-2030)
13.4.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.7. Market Revenue and Forecast, by End user (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Technique (2017-2030)
13.4.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.9. Market Revenue and Forecast, by End user (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Technique (2017-2030)
13.4.10.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.10.5. Market Revenue and Forecast, by End user (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.11.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Technique (2017-2030)
13.4.11.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.11.5. Market Revenue and Forecast, by End user (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.3. Market Revenue and Forecast, by Technique (2017-2030)
13.5.4. Market Revenue and Forecast, by Application (2017-2030)
13.5.5. Market Revenue and Forecast, by End user (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Technique (2017-2030)
13.5.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.5.7. Market Revenue and Forecast, by End user (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Technique (2017-2030)
13.5.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.5.8.5. Market Revenue and Forecast, by End user (2017-2030)
Chapter 14. Company Profiles
14.1. Agilent Technologies, Inc.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Thermo Fisher Scientific Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Lonza
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. MerckKGaA
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Sartorius AG
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Creative Biogene
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Lonza
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Eurofins Scientific
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Codex DNA Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. TransGene Biotech Co. Ltd.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers